RedHill Biopharma Ltd. announced on September 5, 2024, that it has regained compliance with the Nasdaq minimum bid price requirement, successfully maintaining a minimum bid price of $1.00 per share for 10 consecutive days as of September 3, 2024.
AI Assistant
REDHILL BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.